(Q37804438)

23 August 2017

title

Acne fulminans: explosive systemic form of acne (English)

1 reference

23 August 2017

R Zaba

1

1 reference

23 August 2017

Ra Schwartz

2

1 reference

23 August 2017

S Jarmuda

3

1 reference

23 August 2017

M Czarnecka-Operacz

4

1 reference

23 August 2017

W Silny

5

1 reference

23 August 2017

publication date

3 October 2010

1 reference

Journal of the European Academy of Dermatology and Venereology

23 August 2017

published in

1 reference

23 August 2017

volume

25

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

501-507

1 reference

Acne fulminans: report of clinical findings and treatment of twenty-four patients

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acute febrile ulcerative conglobate acne with polyarthralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

The treatment of acne fulminans: a review of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

SAPHO syndrome: a long-term follow-up study of 120 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Testosterone and anabolic steroids and acne fulminans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acne fulminans 'sine fulminans'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acne fulminans coexisting with pyoderma gangrenosum-like eruptions and posterior scleritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Destructive arthritis associated with acne fulminans: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Musculoskeletal syndromes associated with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Acne fulminans and 13-cis-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

Effective treatment of acne fulminans-associated granulation tissue with the pulsed dye laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03855.X

10.1111/J.1468-3083.2010.03855.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference